此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

The Enhancement Effect of Low-Level Laser Therapy for Muscle Training With Combined NMES and BFR

2026年11月10日 更新者:National Cheng-Kung University Hospital

The Enhancement Effect of Low-Level Laser Therapy for Muscle Training With Combined Neuromuscular Electrical Stimulation and Blood Flow Restriction

Blood flow restriction training (BFR) with neuromuscular stimulation (NMES) is employed for individuals with limited mobility and joint issues. However, this approach is highly susceptible to muscle fatigue, despite its potential beneficial effects on muscle strength. Recently, there has been growing interest in using low-level laser therapy (LLLT) to address muscle fatigue. LLLT, known for improving microcirculation and mitochondrial function, shows promise in alleviating enhanced muscle fatigue associated with combined BFR and NMES training. Despite these positive effects, there is limited knowledge about the short-term training impact of combined BFR and NMES with LLLT preconditioning. This project aims to investigate whether the photobiomodulation effects of LLLT could further enhance the training benefits of combined BFR and NMES. The study will employ an integrated analysis of decomposition surface EMG, EEG, and mechanomyogram to explore the behavior and neuromuscular mechanisms underlying the training benefits. If additional benefits are identified, LLLT pre-conditioning is recommended to enhance the use of combined BFR and NMES.

研究概览

研究类型

介入性

注册 (实际的)

44

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Tainan、台湾
        • National Chen Kong University Hospital, Tainan

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

20年 至 40年 (成人)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  1. Healthy adults aged 20-40, without a diagnosis of cardiovascular or neuromusculoskeletal diseases.
  2. Normal vision range after visual correction.

Exclusion Criteria:

  1. Exclude students who have a teacher-student relationship with the principal investigator to ensure the participants' autonomy.
  2. History of brain injury, stroke, spinal cord injury, or other neuromuscular-related conditions.
  3. Contraindications for laser therapy: pregnancy, malignant tumor tissues, bleeding areas, and photosensitive skin regions.
  4. Presence of any contraindications for blood flow restriction training, such as a history of injury or strain in the non-dominant arm's biceps, deep vein thrombosis or venous occlusion in the non-dominant arm, acute unstable fractures in the non-dominant arm, acute regional infections in the non-dominant arm, severe peripheral arterial occlusive disease in the non-dominant arm, complete lymphatic obstruction in the non-dominant arm, and edema due to acute pulmonary edema or congestive heart failure in the non-dominant arm.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:LLLT+BFR+NMES

LLLT: low-level laser therapy BFR: blood flow restriction NMES:neuromuscular Electrical Stimulation

35 min/time, 3 times/weeks, 3 weeks

Low-level laser therapy can increase cellular energy production, making it useful as a pre-conditioning treatment to prevent muscle contraction fatigue or as a post-contraction therapy to accelerate fatigue recovery.

Its advantage is that during training, it can surpass the "overload principle," allowing for effective muscle cross-sectional area growth with relatively light weight training (20%-50% of 1RM or 20%-40% of MVC).

It is a strength training method that uses electrical currents to stimulate nerve and muscle activation, helping to maintain muscle mass, increase blood flow, and slow down or prevent muscle atrophy.

实验性的:BFR+NMES

BFR: blood flow restriction NMES:Neuromuscular Electrical Stimulation

35 min/time, 3 times/weeks, 3 weeks

Its advantage is that during training, it can surpass the "overload principle," allowing for effective muscle cross-sectional area growth with relatively light weight training (20%-50% of 1RM or 20%-40% of MVC).

It is a strength training method that uses electrical currents to stimulate nerve and muscle activation, helping to maintain muscle mass, increase blood flow, and slow down or prevent muscle atrophy.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Myoton
大体时间:before training, 1week of training, 2 weeks of training, at the end of 3 weeks training

Non-dominant hand extensor digitorum muscle belly parameters of static mechanical properties of muscles (Tone, Stiffness, Relaxation, Creep, etc.)

Muscle Mechanical Properties (Myoton) reported in Hertz (Hz) and N/m.

before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Mechanomyogram
大体时间:before training, 1week of training, 2 weeks of training, at the end of 3 weeks training

Recording of extensor digitorum muscle microshock waves during contraction. Mechanomyogram (MMG) signals reported in Volts (V) or m/s²

before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Multi-electrode surface EMG
大体时间:before training, at the end of 3 weeks training

Record muscle activity during contraction. Surface EMG (sEMG) activity reported in Microvolts (μV).

before training, at the end of 3 weeks training
Dynamometer System
大体时间:before training, 1week of training, 2 weeks of training, at the end of 3 weeks training

Measurement to track the degree of force applied by a non-dominant hand.Hand Force (Dynamometer System) reported in N

before training, 1week of training, 2 weeks of training, at the end of 3 weeks training

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Ing-Shiou Hwang, PhD、NCKU, Institute of Allied Health Sciences

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2024年10月1日

初级完成 (实际的)

2025年7月31日

研究完成 (实际的)

2025年7月31日

研究注册日期

首次提交

2024年9月12日

首先提交符合 QC 标准的

2024年12月16日

首次发布 (实际的)

2024年12月18日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月10日

最后验证

2024年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

在美国制造并从美国出口的产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅